1. Home
  2. PMCB vs GCDT Comparison

PMCB vs GCDT Comparison

Compare PMCB & GCDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.34

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

GCDT

Green Circle Decarbonize Technology Limited Ordinary Shares

HOLD

Current Price

$0.29

Market Cap

5.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
GCDT
Founded
1996
1992
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
5.3M
IPO Year
2001
2022

Fundamental Metrics

Financial Performance
Metric
PMCB
GCDT
Price
$0.34
$0.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
164.1K
★ 14.2M
Earning Date
09-14-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.23
52 Week High
$1.51
$5.32

Technical Indicators

Market Signals
Indicator
PMCB
GCDT
Relative Strength Index (RSI) 33.27 42.00
Support Level $0.33 N/A
Resistance Level $0.85 $0.57
Average True Range (ATR) 0.03 0.12
MACD -0.00 -0.02
Stochastic Oscillator 8.64 4.38

Price Performance

Historical Comparison
PMCB
GCDT

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About GCDT Green Circle Decarbonize Technology Limited Ordinary Shares

Green Circle Decarbonize Technology Ltd is a company which provides advanced energy saving solutions supported by proprietary phase change thermal energy storage materials and thermal engineering services. As an advocate of decarbonization, the Company designs, develops and provides customized energy saving solutions that bring considerable economic benefits to our clients and reduce carbon emissions for a sustainable future.

Share on Social Networks: